Search Within

Oscar Boutros Lahoud

Formats
  1. Meeting Abstract (87)
  2. Journal Article (37)
  3. Research Letter (6)
  4. Correspondence (2)
  5. Review (1)
Groups
  1. Department of Medicine (133)
  2. Hematologic Malignancies, Division of (133)
  3. Center for Hematologic Malignancies (129)
  4. Survivorship Research (125)
  5. Bone Marrow Transplant (123)
  6. CTCR Scholars (112)

More Groups

People
  1. Sergio Giralt (107)
  2. Gunjan Shah (105)
  3. Heather Landau (103)
  4. Michael Scordo (98)
  5. David Chung (93)
  6. Hani Hassoun (89)

More People

Years
  1. 2025 (2)
  2. 2024 (11)
  3. 2023 (42)
  4. 2022 (28)
  5. 2021 (10)
  6. 2020 (18)

More Years

Publications
  1. Blood (46)
  2. Clinical Lymphoma, Myeloma and Leukemia (26)
  3. Biology of Blood and Marrow Transplantation (10)
  4. Blood Advances (9)
  5. Journal of Clinical Oncology (8)
  6. Leukemia and Lymphoma (6)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Elsevier Inc. (41)
  3. American Society of Clinical Oncology (8)
  4. Nature Publishing Group (7)
  5. Taylor & Francis Group (6)
  6. John Wiley & Sons (3)

More Publishers

Results (133)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Meeting Abstract

    Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Capture rate of V(D)J sequencing for minimal residual disease detection in multiple myeloma
    Journal Article

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Jacob, A.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Smith, E. L.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world experience
    Meeting Abstract

    Hultcrantz, M.; Orozco, J.; Peterson, T. J.; Derkach, A.; Hassoun, H.; Korde, N.; Lu, S. X.; Mailankody, S.; Patel, D.; Shah, U. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplant: Interim analysis of the multicenter 2nd chance protocol
    Meeting Abstract

    Shah, G.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R.; Costa, L.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
    Journal Article

    Lahoud, O. B.; Devlin, S. M.; Maloy, M. A.; Roeker, L. E.; Dahi, P. B.; Ponce, D. M.; Gyurkocza, B.; Koehne, G.; Young, J. W.; Castro-Malaspina, H. R.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save